Clinical trial
Is Autotaxin a Promising Biomarker for Breast Cancer
NCT05680311 is registered in ClinicalTrials.gov with Ankara Etlik City Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is Autotaxin a Promising Biomarker for Breast Cancer
- Lead sponsor
- Ankara Etlik City Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2019
- Completion date
- March 15, 2021
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer